Welcome

The ELEVATE 2022 virtual meeting is now available to watch on-demand. Re-live this insightful meeting
where we heard from an esteemed faculty exploring the efficacy and effectiveness of CDK4/6 inhibitors in
HR+/HER2- aBC through plenary sessions and a panel discussion. The meeting Chair, Prof. Hope S. Rugo,
was joined by Dr Gabrielle Rocque and Dr Maggie Banys-Paluchowski during this 60-minute educational
webinar focused on education, evidence and experience.



Speakers

Prof. Hope S. Rugo

See Bio

Dr Gabrielle Rocque

See Bio

Dr Maggie Banys-Paluchowski

See Bio

Agenda

Time
Session Title
Presenter
7 July 2022
Latest advances of CDK4/6 inhibitors: Confidence and impact on
clinical practices
Chair: Prof. Hope S. Rugo
5 minutes
Welcome and introduction
Prof. Hope S. Rugo
15 minutes
Treatment benefit of CDK4/6 inhibitors in HR+/HER2- aBC
in clinical trials and the real world
Prof. Hope S. Rugo
10 minutes
The increasing role of RWE in complementing clinical trial results
and healthcare decisions
Dr Gabrielle Rocque
10 minutes
Optimising management of HR+/HER2- aBC (clinical experience)
Dr Maggie Banys-Paluchowski
15 minutes
Panel discussion and Q&A
Dr Gabrielle Rocque
Dr Maggie Banys-Paluchowski
Facilitated by: Prof. Hope S. Rugo
5 minutes
Close and summary
Prof. Hope S. Rugo